{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Examen neurologique : Questions médicales les plus fréquentes",
"headline": "Examen neurologique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Examen neurologique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-05",
"dateModified": "2025-02-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Examen neurologique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Examen physique",
"url": "https://questionsmedicales.fr/mesh/D010808",
"about": {
"@type": "MedicalCondition",
"name": "Examen physique",
"code": {
"@type": "MedicalCode",
"code": "D010808",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E01.370.600"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Échelle de mesure des mouvements involontaires anormaux",
"alternateName": "Abnormal Involuntary Movement Scale",
"url": "https://questionsmedicales.fr/mesh/D000067399",
"about": {
"@type": "MedicalCondition",
"name": "Échelle de mesure des mouvements involontaires anormaux",
"code": {
"@type": "MedicalCode",
"code": "D000067399",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E01.370.600.550.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mesure de la douleur",
"alternateName": "Pain Measurement",
"url": "https://questionsmedicales.fr/mesh/D010147",
"about": {
"@type": "MedicalCondition",
"name": "Mesure de la douleur",
"code": {
"@type": "MedicalCode",
"code": "D010147",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E01.370.600.550.324"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Examen neurologique",
"alternateName": "Neurologic Examination",
"code": {
"@type": "MedicalCode",
"code": "D009460",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Lizabeth C Lueck",
"url": "https://questionsmedicales.fr/author/Lizabeth%20C%20Lueck",
"affiliation": {
"@type": "Organization",
"name": "University of Wisconsin-Madison, Madison, Wisconsin, USA."
}
},
{
"@type": "Person",
"name": "Starr Cameron",
"url": "https://questionsmedicales.fr/author/Starr%20Cameron",
"affiliation": {
"@type": "Organization",
"name": "University of Wisconsin-Madison, Madison, Wisconsin, USA."
}
},
{
"@type": "Person",
"name": "Natalia Zidan",
"url": "https://questionsmedicales.fr/author/Natalia%20Zidan",
"affiliation": {
"@type": "Organization",
"name": "University of Wisconsin-Madison, Madison, Wisconsin, USA."
}
},
{
"@type": "Person",
"name": "Jochen Brich",
"url": "https://questionsmedicales.fr/author/Jochen%20Brich",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology and Neuroscience, Medical Center, University of Freiburg, Freiburg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Experience of Public Health Departments in Implementation of COVID-19 Case Investigation and Contact Tracing Programs.",
"datePublished": "2024-05-23",
"url": "https://questionsmedicales.fr/article/38779998",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00333549241239556"
}
},
{
"@type": "ScholarlyArticle",
"name": "Single-cell network analysis reveals gene expression programs for Arabidopsis root development and metabolism.",
"datePublished": "2024-05-22",
"url": "https://questionsmedicales.fr/article/38783601",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.xplc.2024.100978"
}
},
{
"@type": "ScholarlyArticle",
"name": "Preoperative Education is Associated with Adherence to Downstream Components and Outcomes in a Colorectal Surgery Enhanced Recovery Program.",
"datePublished": "2024-05-16",
"url": "https://questionsmedicales.fr/article/38911622",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/AS9.0000000000000432"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sociodemographic and clinical correlates of hallucinations in patients entering an early intervention program for first episode psychosis.",
"datePublished": "2024-05-15",
"url": "https://questionsmedicales.fr/article/38754313",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.schres.2024.04.026"
}
},
{
"@type": "ScholarlyArticle",
"name": "A novel signature based on twelve programmed cell death patterns to predict the prognosis of lung adenocarcinoma.",
"datePublished": "2024-05-15",
"url": "https://questionsmedicales.fr/article/38883377",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.62347/UAMN8558"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Diagnostic",
"item": "https://questionsmedicales.fr/mesh/D003933"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques et procédures diagnostiques",
"item": "https://questionsmedicales.fr/mesh/D019937"
},
{
"@type": "ListItem",
"position": 4,
"name": "Examen physique",
"item": "https://questionsmedicales.fr/mesh/D010808"
},
{
"@type": "ListItem",
"position": 5,
"name": "Examen neurologique",
"item": "https://questionsmedicales.fr/mesh/D009460"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Examen neurologique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Examen neurologique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Examen neurologique",
"description": "Quels tests sont utilisés lors d'un examen neurologique ?\nComment évaluer la fonction cognitive ?\nQu'est-ce qu'un examen neurologique complet ?\nQuand un examen neurologique est-il nécessaire ?\nQuel rôle joue l'imagerie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Program+Evaluation&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Examen neurologique",
"description": "Quels sont les symptômes d'une lésion nerveuse ?\nComment reconnaître un AVC ?\nQuels symptômes indiquent une maladie neurodégénérative ?\nQuels signes peuvent indiquer une migraine ?\nQuels symptômes sont associés à la sclérose en plaques ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Program+Evaluation&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Examen neurologique",
"description": "Comment prévenir les AVC ?\nQuelles mesures pour éviter les migraines ?\nComment réduire le risque de maladies neurodégénératives ?\nQuelles sont les stratégies de prévention pour la neuropathie ?\nComment prévenir les blessures à la tête ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Program+Evaluation&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Examen neurologique",
"description": "Quels traitements sont disponibles pour les migraines ?\nComment traiter une neuropathie périphérique ?\nQuelles sont les options pour l'AVC ?\nComment gérer les symptômes de la sclérose en plaques ?\nQuels traitements sont efficaces pour les troubles de l'humeur ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Program+Evaluation&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Examen neurologique",
"description": "Quelles complications peuvent survenir après un AVC ?\nQuels risques sont associés à la sclérose en plaques ?\nQuelles complications peuvent résulter d'une neuropathie ?\nQuels effets secondaires des traitements neurologiques ?\nQuelles complications psychologiques peuvent survenir ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Program+Evaluation&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Examen neurologique",
"description": "Quels sont les facteurs de risque pour les AVC ?\nQuels facteurs augmentent le risque de migraines ?\nQuels sont les facteurs de risque pour la sclérose en plaques ?\nQuels facteurs influencent la neuropathie ?\nQuels sont les facteurs de risque pour les troubles de l'humeur ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Program+Evaluation&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Quels tests sont utilisés lors d'un examen neurologique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'évaluation des réflexes, la force musculaire et la coordination."
}
},
{
"@type": "Question",
"name": "Comment évaluer la fonction cognitive ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fonction cognitive est évaluée par des tests de mémoire, d'attention et de langage."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'un examen neurologique complet ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il inclut l'évaluation des nerfs crâniens, de la motricité et de la sensibilité."
}
},
{
"@type": "Question",
"name": "Quand un examen neurologique est-il nécessaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est nécessaire en cas de symptômes neurologiques comme des maux de tête ou des vertiges."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'imagerie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie, comme l'IRM, aide à visualiser les anomalies cérébrales ou médullaires."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une lésion nerveuse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent engourdissement, faiblesse musculaire et douleurs neuropathiques."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un AVC ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une faiblesse soudaine, des troubles de la parole et des maux de tête."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une maladie neurodégénérative ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles de la mémoire, des changements de comportement et des tremblements."
}
},
{
"@type": "Question",
"name": "Quels signes peuvent indiquer une migraine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs unilatérales, des nausées et une sensibilité à la lumière."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à la sclérose en plaques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, troubles de la vision et problèmes d'équilibre."
}
},
{
"@type": "Question",
"name": "Comment prévenir les AVC ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un mode de vie sain, le contrôle de la pression artérielle et l'arrêt du tabac."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter les migraines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs, maintenir une bonne hydratation et gérer le stress peuvent aider."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de maladies neurodégénératives ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie actif, une alimentation équilibrée et des activités cognitives peuvent aider."
}
},
{
"@type": "Question",
"name": "Quelles sont les stratégies de prévention pour la neuropathie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Contrôler le diabète, éviter l'alcool et maintenir une bonne nutrition sont essentiels."
}
},
{
"@type": "Question",
"name": "Comment prévenir les blessures à la tête ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Porter un casque, éviter les activités à risque et sécuriser l'environnement sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les migraines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des analgésiques, des médicaments préventifs et des thérapies comportementales."
}
},
{
"@type": "Question",
"name": "Comment traiter une neuropathie périphérique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des médicaments pour la douleur, la physiothérapie et des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "Quelles sont les options pour l'AVC ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent des médicaments thrombolytiques et la réhabilitation post-AVC."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes de la sclérose en plaques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut des médicaments immunomodulateurs et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces pour les troubles de l'humeur ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la psychothérapie, les antidépresseurs et les thérapies cognitives."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après un AVC ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles de la parole, des problèmes de mobilité et des infections."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à la sclérose en plaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des infections, des complications urinaires et des problèmes de mobilité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une neuropathie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des blessures dues à une perte de sensation et des infections."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des traitements neurologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Quelles complications psychologiques peuvent survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'anxiété, la dépression et des troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les AVC ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de migraines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le stress, les changements hormonaux et certains aliments."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour la sclérose en plaques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent la neuropathie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète, l'alcoolisme et certaines carences nutritionnelles sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles de l'humeur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, le stress et des événements traumatiques."
}
}
]
}
]
}
Case investigation and contact tracing (CI/CT) are fundamental public health efforts widely used during the COVID-19 pandemic to mitigate transmission. This study investigated how state, local, and tr...
During March and April 2022, we conducted key informant interviews with up to 3 public health officials from 43 state, local, and tribal public health departments. From audio-recorded and transcribed ...
Major adjustments to CI/CT protocols during the pandemic included (1) prioritizing populations for outreach; (2) implementing automated outreach for nonprioritized groups, particularly during COVID-19...
When addressing future epidemics or outbreaks, public health officials should consider strategies that improve the effectiveness of CI/CT efforts over time, such as prioritizing populations based on d...
Single-cell RNA-seq (scRNA-seq) datasets of Arabidopsis roots have been generated, but related comprehensive gene co-expression network analyses are lacking. We conducted a single-cell gene co-express...
This study evaluated the association between preoperative education and adherence to downstream components of enhanced recovery programs (ERPs) and surgical outcomes among patients undergoing elective...
ERPs improve outcomes for surgical patients. While preoperative education is an essential component of ERPs, its relationship with other components is unclear....
This was a retrospective cohort study of all ERP patients undergoing elective colorectal surgery from 2019 to 2022. Our institutional ERP database was linked with American College of Surgeons National...
A total of 997 patients were included. The mean (SD) age was 56.5 (15.8) years, 686 (57.3%) were female, and 717 (71.9%) were white. On adjusted analysis, patients who received preoperative education ...
Preoperative education is associated with adherence to ERP components and improved surgical outcomes....
Hallucinations are a core feature of psychosis, and their severity during the acute phase of illness is associated with a range of poor outcomes. Various clinical and sociodemographic factors may pred...
Programmed cell death (PCD) plays a pivotal role in tumor initiation and progression. However, the prognostic value and clinical characteristics of PCD-related genes (PRGs) remain unclear. We collecte...
Recent developments in immunotherapy, including immune checkpoint blockade (ICB) and adoptive cell therapy, have encountered challenges such as immune-related adverse events and resistance, especially...
Catheter-associated urinary tract infections (CAUTIs) account for a large proportion of healthcare-associated infections and have a significant impact on morbidity, length of hospital stay, and mortal...
Intervention programs, including training, surveillance, and monitoring, were implemented. Data on the microorganisms responsible for CAUTIs, urinary catheter utilization ratio, rate of CAUTIs per 1,0...
Thirty-two hospitals participated in the study, including 21 university hospitals and 11 small- and medium-sized hospitals. The microorganisms responsible for CAUTIs and their resistance rates did not...
We implemented interventions to prevent CAUTIs and evaluated their outcomes. The incidence of these infections decreased in the initial phases of the intervention when adequate support and personnel w...
The advanced access (AA) model is among the most recommended innovations for improving timely access in primary care (PC). AA is based on core pillars such as comprehensive planning for care needs and...
A cross-sectional online survey was sent to the chief resident and academic director at each participating clinic. An overall response rate of 96% (44/46 U-FMGs) was obtained....
No local residency program was deemed compatible with all four considered pillars. On planning for needs and supply, only one quarter of the programs were compatible with the principles of AA, owing t...
Our study highlights the heterogeneity among local residency programs with respect to their theoretical compatibility with the key principles of AA. Future research to empirically test the hypotheses ...
English is generally recognized as the international language of science and most research on evidence-based medicine is produced in English. While Bangla is the dominant language in Bangladesh, publi...
This mixed-methods study investigates the challenges and opportunities associated with the implementation of EMI in the context of diploma midwifery education in Bangladesh. Surveys were sent to princ...
Surveys found that English instructors are primarily guest lecturers, trained in general or business English, without a standardized curriculum or functional English language laboratories. Three theme...
ESP, which teaches English for application in a specific discipline, is one option available in Bangladesh for midwifery education. Native language instruction and the middle ground of multilingualism...
Infections are a safety concern in patients with ulcerative colitis (UC). Etrasimod is an oral, once-daily (QD), selective sphingosine 1phosphate (S1P)1,4,5 receptor modulator for the treatment of mod...
Proportions, incidence rates (IRs; per 100 patient-years) and descriptive analyses of all, serious, severe, herpes zoster, and opportunistic infections are reported in the Pivotal UC cohort (ELEVATE U...
In this analysis (n=787), proportions (IRs) of all infection events were similar for patients receiving etrasimod 2 mg QD (18.8% [41.1]) or placebo (17.7% [49.0]). Serious infections occurred in three...
Patients receiving etrasimod demonstrated no increased risk of infection. The incidence of serious infections and herpes zoster was similar in each group. Among patients receiving etrasimod, no associ...